A Oneindia Venture

JM Financial Vows Full Cooperation With Sebi Amidst Regulatory Probe

In response to regulatory action by the Securities and Exchange Board of India (Sebi), JM Financial Ltd has pledged its full cooperation with the investigation into alleged irregularities surrounding the public issue of debt securities. Sebi's directive, which prohibits JM Financial from accepting new mandates as a lead manager for such public offerings due to regulatory violations, underscores the heightened scrutiny faced by financial institutions in India.

While Sebi's interim order allows JM Financial to continue serving as a lead manager for existing mandates in this domain for a limited period of 60 days, the regulatory body has initiated a thorough investigation into the matter. This investigation, set to be completed within six months, follows a routine examination of public issues of Non-Convertible Debentures (NCD) conducted in 2023.

JM Financial Vows Full Cooperation With Sebi Amidst Regulatory Probe

The acts of JM Financial and its affiliated companies in relation to a particular debt issue are the main subject of Sebi's examination. In its interim order, Sebi expressed profound concern over the handling of subscriptions in this public offering, describing the tactics employed as "shocking." Sebi highlighted alleged premeditated strategies aimed at ensuring subscription and success at every stage of the debt issuance process.

Specifically, Sebi noted that JM Financial and its associated entities allegedly provided certain investors with an assured exit at a profit, thereby incentivizing their participation in the public offering in contravention of regulatory mandates. The scheme reportedly involved enticing individual investors, who may not have otherwise participated, to apply for the offering by not only providing funds but also guaranteeing them a profitable exit on the listing day.

Furthermore, Sebi's scrutiny of investors' bank statements, operated through Power of Attorney (PoA) by JM Group entities, suggests that such practices may be prevalent across various public offerings. Sebi's interim order underscores the need for a thorough investigation into these practices, with implications for broader regulatory reforms in the capital markets landscape.

JM Financial has assured its full cooperation with Sebi's probe in a filing to the stock exchanges. This development follows closely on the heels of the Reserve Bank of India's decision to prohibit JM Financial Products Ltd from extending any form of financing against shares and debentures, including loans against initial public offerings (IPOs) added BSE Filling.

The recent regulatory actions against JM Financial highlight the importance of upholding regulatory compliance and transparency in capital market operations. As the investigation unfolds, stakeholders will closely monitor developments and await Sebi's final decision, which may have far-reaching implications for JM Financial and the regulatory landscape governing public offerings and debt securities issuance in India.

Market participants are advised to exercise caution and vigilance when navigating the capital markets landscape, emphasizing regulatory compliance and adherence to ethical business practices. The outcome of Sebi's probe will likely influence market participants' risk assessment and due diligence processes when engaging with financial intermediaries.

Regulatory agencies are ever-vigilant in defending investor interests and upholding market integrity as the financial sector develops. JM Financial's cooperation with the investigation underscores the importance of accountability and transparency in fostering trust and confidence in India's financial ecosystem.

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+